High Levels of Systemic Myeloperoxidase Are Associated With Coronary Plaque Erosion in Patients With Acute Coronary Syndromes
Author(s) -
Giuseppe Ferrante,
Masataka Nakano,
Francesco Prati,
Giampaolo Niccoli,
Maria Teresa Mallus,
Vito Ramazzotti,
Rocco Antonio Montone,
Frank D. Kolodgie,
Renu Virmani,
Filippo Crea
Publication year - 2010
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.110.955302
Subject(s) - medicine , cardiology , myeloperoxidase , acute coronary syndrome , coronary atherosclerosis , coronary heart disease , inflammation , myocardial infarction
Systemic levels of myeloperoxidase predict prognosis in patients with acute coronary syndromes and are considered a marker of plaque vulnerability. It is not known whether myeloperoxidase is associated with different coronary morphologies (ie, rupture or erosion of the culprit lesion) in patients with acute coronary syndrome.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom